2-methoxyestradiol analogue ENMD-1198 reduces breast cancer-induced osteolysis and tumor burden both in vitro and in vivo. [electronic resource]
Producer: 20110909Description: 874-82 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- pharmacology
- Bone Neoplasms -- pathology
- Bone Resorption -- drug therapy
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Estrenes -- pharmacology
- Female
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Osteoclasts -- drug effects
- Osteolysis -- drug therapy
- Pregnancy
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.